Multiple patent filings have been submitted to USPTO. As of this writing, all of them remain subject to 35 U.S.C. 122(b)(2)(B)(i) publication bans. They may only be examined under NDA with the company’s prior written authorization. Registered trademark and copyright filings have also been submitted to CIPO.
